Spyre Therapeutics, Inc.
public$SYRE View Live Feed →
Total Raised
--
Contracts
--
Patents
--
PAC Giving
--
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
No recent news or market intelligence found for this entity.
Congressional Trades in $SYRE
No disclosed congressional trades found in $SYRE.
Insider Trades (Form 4)
SELLChief Financial Officer
Burrows Scott L
$1,524,50030,000 shares Jun 27, 2026
SELLDirector
Kiselak Tomas
$399,658,6675,351,461 shares Jun 24, 2026
SELLDirector
HENDERSON MICHAEL THOMAS
$2,000,00020,000 shares Jun 24, 2026
GRANTDirector
Kiselak Tomas
8,026 shares May 29, 2026
GRANTDirector
Fairmount Funds Management LLC
8,026 shares May 29, 2026
GRANTDirector
Fairmount Healthcare Fund II L.P.
8,026 shares May 29, 2026
GRANTDirector
Albers Jeffrey W.
8,026 shares May 29, 2026
GRANTDirector
HENDERSON MICHAEL THOMAS
8,026 shares May 29, 2026
Key People
Burrows Scott L
Chief Financial Officer
Insider
Kiselak Tomas
Director
BoardInsider
Fairmount Funds Management LLC
Director
BoardInsider
Stelzer Laurie
Director
BoardInsider
Milligan Sandra
Director
BoardInsider
McKenna Mark C
Director
BoardInsider
Albers Jeffrey W
Director
BoardInsider
Fairmount Healthcare Fund L P
Director
BoardInsider
HENDERSON MICHAEL THOMAS
Director
BoardInsider
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro